FP7Individual fellowship2009–2011

YLIDXCHEM · DEVELOPMENT AND APPLICATIONS OF NEW YLID CHEMISTRY

FP7 — People (Marie Curie Actions)

Duration
2009-07-01 → 2011-06-30
EU contribution
€171,868
Participants
1
Scheme
MC-IEF

Lines connect the coordinator with its partners.

Results in brief

DEVELOPMENT AND APPLICATIONS OF NEW YLID CHEMISTRY

Using new oxonium ylid formation [2,3] sigmatropic rearrangement chemistry we developed a tenstep asymmetric synthesis of hyperolactone C (8) from (S)-styrene oxide (1) (Scheme 1). Hyperolactone C (8) was originally isolated from the leaves and stems of Hypericum chinese L. (1995) as a part of a small family of related lactones. Hyperolactone C and ent-zingiberene are precursors of biyouyanagin A, a new anti-HIV agent. This work built upon an earlier racemic Hodgson synthesis. First of all a new synthetic pathway to chiral diazo ether 2 from 1 was developed. Since styrene oxide along with related epoxides are commercially available in both enantiomeric forms (via kinetic resolution), the method could be considered as more general entry to chiral diazo ethers. Also, a series of chiral auxiliaries (thiazolidine-2-thiones) in combination with Masamune homologation was systematically examined in the synthesis of 2, but was shown to be a less efficient strategy. We established that distabilized diazo compounds like 2 are stable enough to survive ozonolysis to form an aldehyde that underwent olefination with a stabilized Wittig reagent to give enone 3. By this approach a previously unreliable cross-metathesis5 was replaced in the current synthesis of enone 3. Lactone 7 was prepared from enone 3 by a four-step sequence, with only one chromatographic purification being required. The sequence was: reduction, silylation, Rh2-cat. oxonium ylid formation–rearrangement and then acid cat. desilylation–lactonization. Lactone 7 was formed preferentially alongside the other three possible diastereomers. Finally, (–)-hyperolactone C (8) was prepared by one-pot silylation–DDQ oxidation of lactone 7, under mild conditions. It is important to note that all of the diazo compounds 3, 4 and 5 underwent oxonium ylid formation–rearrangement and could be used for the synthesis of lactone 7 as the major product; however, using silyloxy ester 5 was identified as the optimal route. The key oxonium ylid formation–rearrangement step (Scheme 2), could proceed by four possible pathways, forming four diastereomers with two new quaternary stereocenters, 12 being the major and desired. Rh. cat. “decomposition” of diazo compound 9 gives ylid 10 followed by [2,3] sigmatropic rearrangement preferentially via endo-TS. Also, the Ph group on the furanone ring could be in two relative orientations with respect to ester group with preferable cis orientation. No effect of catalyst (Rh2(OAc)4 or Rh2(TFA)4) on the selectivity of reaction was observed. Reactant 9, bearing a CH=O group, showed high preference for cis orientation (>90 %, Ph – CO2R), but relatively low preference for endo-TSs (~80 %) and practically no effect of R ester group size. Also, a significant quantity (~25 %) of side product 11, probably formed via [1,2] shift, was observed. On the other hand, hydroxy and silyloxy derivatives 9 gave only products of [2,3] rearrangement and showed high endo selectivity (>93 %). Interesting, an increase in face selectivity with a decrease in R size and with OH protection by TMS (52 – 74 % for OH and 74 – 85 % for OTMS) was observed.

Data: CORDIS, © European Union

Project objective

The aims of this research are to develop efficient synthetic methodology for one-pot catalytic cross-metathesis/tandem oxonium ylide formation– [2,3] sigmatropic rearrangement of unsaturated diazocarbonyl substrates, to establish a pool of useful chiral catalysts for this chemistry, and to apply this methodology in strategies for the enantioselective synthesis of selected biologically active natural product classes. The objectives are: Development and scope of one-pot cross-metathesis/tandem oxonium ylide formation– [2,3] sigmatropic rearrangement New catalyst preparation and evaluation in enantioselective tandem ylide formation – rearrangement Development of asymmetric synthesis strategies to hyperolactone anti-HIV agents

Original text from CORDIS.

Participants

  • THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD · OxfordCoordinatorUnited Kingdom

Links

Data: CORDIS, © European Union